$RPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REPROS THERAPEUTICS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REPROS THERAPEUTICS INC.. Get notifications about new insider transactions in REPROS THERAPEUTICS INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | D | 0.32 | 5,000 | 1,600 | 0 | |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Sell | D | 0.67 | 27,779 | 18,612 | 0 | 27.8 K to 0 (-100.00 %) |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Sell | U | 0.67 | 21,580 | 14,459 | 27,779 | 49.4 K to 27.8 K (-43.72 %) |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Option Exercise | D | 0.32 | 5,000 | 1,600 | 0 | |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Sell | D | 0.67 | 27,779 | 18,612 | 0 | 27.8 K to 0 (-100.00 %) |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Sell | U | 0.67 | 12,221 | 8,188 | 27,779 | 40 K to 27.8 K (-30.55 %) |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | Ramasastry Saira | Director | Option Exercise | D | 0.32 | 5,000 | 1,600 | 0 | |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | Ramasastry Saira | Director | Sell | D | 0.67 | 27,779 | 18,612 | 0 | 27.8 K to 0 (-100.00 %) |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | Ramasastry Saira | Director | Sell | U | 0.67 | 12,221 | 8,188 | 27,779 | 40 K to 27.8 K (-30.55 %) |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | D | 0.32 | 5,000 | 1,600 | 0 | |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Sell | D | 0.67 | 27,779 | 18,612 | 0 | 27.8 K to 0 (-100.00 %) |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Sell | U | 0.67 | 12,221 | 8,188 | 27,779 | 40 K to 27.8 K (-30.55 %) |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | D | 0.32 | 5,000 | 1,600 | 0 | |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Sell | D | 0.67 | 27,779 | 18,612 | 0 | 27.8 K to 0 (-100.00 %) |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Sell | U | 0.67 | 23,221 | 15,558 | 27,779 | 51 K to 27.8 K (-45.53 %) |
Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | CHIEF FINANCIAL OFF ... | Sell | U | 0.67 | 83,875 | 56,196 | 0 | 83.9 K to 0 (-100.00 %) |
Sep 18 2017 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | A | 0.32 | 5,000 | 1,600 | 5,000 | |
Sep 18 2017 | RPRX | REPROS THERAPEUTIC ... | Ramasastry Saira | Director | Option Exercise | A | 0.32 | 5,000 | 1,600 | 5,000 | |
Sep 18 2017 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 0.32 | 5,000 | 1,600 | 5,000 | |
Sep 18 2017 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | President and CEO | Option Exercise | A | 0.32 | 5,000 | 1,600 | 5,000 | |
Sep 18 2017 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 0.32 | 5,000 | 1,600 | 5,000 | |
Jul 05 2017 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 83,875 | 73.9 K to 83.9 K (+13.54 %) |
Jun 02 2017 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 73,875 | 63.9 K to 73.9 K (+15.66 %) |
May 01 2017 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 63,875 | 53.9 K to 63.9 K (+18.56 %) |
Apr 04 2017 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 53,875 | 43.9 K to 53.9 K (+22.79 %) |
Feb 15 2017 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Grant | A | 0.00 | 40,000 | 0 | 49,359 | 9.4 K to 49.4 K (+427.40 %) |
Feb 15 2017 | RPRX | REPROS THERAPEUTIC ... | Ramasastry Saira | Director | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Feb 15 2017 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Grant | A | 0.00 | 40,000 | 0 | 51,000 | 11 K to 51 K (+363.64 %) |
Feb 15 2017 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Feb 15 2017 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Feb 03 2017 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 33,875 | 23.9 K to 33.9 K (+41.88 %) |
Dec 09 2016 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 1.60 | 20,000 | 32,000 | 107,422 | 87.4 K to 107.4 K (+22.88 %) |
Nov 23 2016 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Sell | S | 1.95 | 3,305 | 6,445 | 0 | 3.3 K to 0 (-100.00 %) |
Jul 06 2016 | RPRX | REPROS THERAPEUTIC ... | Wernicke J. F. | Chief Medical Offic ... | Option Exercise | A | 1.73 | 10,000 | 17,300 | 10,000 | |
Jul 06 2016 | RPRX | REPROS THERAPEUTIC ... | Thompson Jaye | See Remarks | Option Exercise | A | 1.73 | 10,000 | 17,300 | 10,000 | |
Jul 05 2016 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 1.61 | 5,000 | 8,050 | 5,000 | |
Jul 05 2016 | RPRX | REPROS THERAPEUTIC ... | Ramasastry Saira | Director | Option Exercise | A | 1.61 | 5,000 | 8,050 | 5,000 | |
Jul 05 2016 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | A | 1.61 | 5,000 | 8,050 | 5,000 | |
Jul 05 2016 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Option Exercise | A | 1.61 | 5,000 | 8,050 | 5,000 | |
Jul 05 2016 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 1.61 | 5,000 | 8,050 | 5,000 | |
May 16 2016 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Option Exercise | A | 2.06 | 100,000 | 206,000 | 100,000 | |
Feb 19 2016 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 0.93 | 10,000 | 9,300 | 87,422 | 77.4 K to 87.4 K (+12.92 %) |
Jan 28 2016 | RPRX | REPROS THERAPEUTIC ... | Wernicke J. F. | Chief Medical Offic ... | Buy | P | 1.11 | 8,400 | 9,324 | 10,000 | 1.6 K to 10 K (+525.00 %) |
Jan 28 2016 | RPRX | REPROS THERAPEUTIC ... | Wernicke J. F. | Chief Medical Offic ... | Buy | P | 1.13 | 980 | 1,107 | 1,600 | 620 to 1.6 K (+158.06 %) |
Jan 28 2016 | RPRX | REPROS THERAPEUTIC ... | Wernicke J. F. | Chief Medical Offic ... | Buy | P | 1.12 | 620 | 694 | 620 | 0 to 620 |
Jan 28 2016 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Buy | P | 1.08 | 12,000 | 12,960 | 23,875 | 11.9 K to 23.9 K (+101.05 %) |
Jan 07 2016 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 1.14 | 3,500 | 3,990 | 77,422 | 73.9 K to 77.4 K (+4.73 %) |
Jan 07 2016 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 1.20 | 8,177 | 9,804 | 73,922 | 65.7 K to 73.9 K (+12.44 %) |
Jun 01 2015 | RPRX | REPROS THERAPEUTIC ... | Ramasastry Saira | Director | Option Exercise | A | 7.26 | 5,000 | 36,300 | 5,000 | |
Jun 01 2015 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | A | 7.26 | 5,000 | 36,300 | 5,000 | |
Jun 01 2015 | RPRX | REPROS THERAPEUTIC ... | Suesserman Michael | Director | Option Exercise | A | 7.26 | 5,000 | 36,300 | 5,000 | |
Jun 01 2015 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 7.26 | 5,000 | 36,300 | 5,000 | |
Jun 01 2015 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 7.26 | 5,000 | 36,300 | 5,000 | |
Feb 09 2015 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | A | 8.44 | 30,000 | 253,200 | 30,000 | |
Feb 09 2015 | RPRX | REPROS THERAPEUTIC ... | Suesserman Michael | Director | Option Exercise | A | 8.44 | 30,000 | 253,200 | 30,000 | |
Feb 09 2015 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 8.44 | 30,000 | 253,200 | 30,000 | |
Feb 09 2015 | RPRX | REPROS THERAPEUTIC ... | Ramasastry Saira | Director | Option Exercise | A | 8.44 | 30,000 | 253,200 | 30,000 | |
Feb 09 2015 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 8.44 | 30,000 | 253,200 | 30,000 | |
Feb 09 2015 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Option Exercise | A | 8.44 | 30,000 | 253,200 | 30,000 | |
Nov 12 2014 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Buy | P | 9.41 | 3,500 | 32,952 | 11,875 | 8.4 K to 11.9 K (+41.79 %) |
Nov 12 2014 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 9.42 | 4,700 | 44,274 | 65,745 | 61 K to 65.7 K (+7.70 %) |
Sep 17 2014 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Buy | P | 14.34 | 200 | 2,868 | 3,305 | 3.1 K to 3.3 K (+6.44 %) |
Aug 14 2014 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 13.91 | 2,100 | 29,211 | 61,045 | 58.9 K to 61 K (+3.56 %) |
Aug 14 2014 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Buy | P | 13.85 | 2,000 | 27,700 | 8,375 | 6.4 K to 8.4 K (+31.37 %) |
Jun 17 2014 | RPRX | REPROS THERAPEUTIC ... | Ramasastry Saira | Director | Option Exercise | A | 16.54 | 5,000 | 82,700 | 5,000 | |
Jun 17 2014 | RPRX | REPROS THERAPEUTIC ... | Suesserman Michael | Director | Option Exercise | A | 16.54 | 5,000 | 82,700 | 5,000 | |
Jun 17 2014 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | A | 16.54 | 5,000 | 82,700 | 5,000 | |
Jun 17 2014 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 16.54 | 5,000 | 82,700 | 5,000 | |
Jun 17 2014 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 16.54 | 5,000 | 82,700 | 5,000 | |
Mar 27 2014 | RPRX | REPROS THERAPEUTIC ... | Wiehle Ronald | VP, Research and De ... | Option Exercise | A | 17.47 | 75,000 | 1,310,250 | 75,000 | |
Mar 27 2014 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 17.47 | 150,000 | 2,620,500 | 150,000 | |
Jan 21 2014 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | CHIEF FINANCIAL OFF ... | Option Exercise | A | 21.48 | 5,000 | 107,400 | 5,000 | |
Jan 10 2014 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | M | 9.60 | 10,000 | 96,000 | 0 | |
Jan 10 2014 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Buy | M | 9.60 | 10,000 | 96,000 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
Dec 23 2013 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | A | 18.78 | 20,000 | 375,600 | 56,668 | |
Nov 14 2013 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Buy | P | 14.97 | 500 | 7,485 | 1,000 | 500 to 1,000 (+100.00 %) |
Oct 25 2013 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Buy | P | 17.90 | 1,000 | 17,900 | 6,375 | 5.4 K to 6.4 K (+18.60 %) |
Oct 25 2013 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 18.03 | 3,000 | 54,102 | 58,945 | 55.9 K to 58.9 K (+5.36 %) |
Oct 11 2013 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Buy | P | 23.77 | 1,000 | 23,770 | 5,375 | 4.4 K to 5.4 K (+22.86 %) |
Jun 21 2013 | RPRX | REPROS THERAPEUTIC ... | Ramasastry Saira | Director | Option Exercise | A | 19.19 | 5,000 | 95,950 | 45,000 | |
Jun 21 2013 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 19.19 | 5,000 | 95,950 | 69,250 | |
Jun 21 2013 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 19.19 | 5,000 | 95,950 | 80,000 | |
Jun 21 2013 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | A | 19.19 | 5,000 | 95,950 | 36,668 | |
Mar 28 2013 | RPRX | REPROS THERAPEUTIC ... | Thompson Jaye | Senior Vice Preside ... | Option Exercise | A | 8.95 | 100,000 | 895,000 | 100,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 10.00 | 500 | 5,000 | 22,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 12.50 | 500 | 6,250 | 22,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 12.50 | 500 | 6,250 | 23,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 10.00 | 500 | 5,000 | 23,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 10.00 | 1,000 | 10,000 | 24,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 12.50 | 1,000 | 12,500 | 25,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 12.50 | 1,500 | 18,750 | 26,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 12.50 | 2,000 | 25,000 | 27,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 12.50 | 6,000 | 75,000 | 29,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 10.00 | 500 | 5,000 | 35,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 12.50 | 1,000 | 12,500 | 36,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 12.50 | 1,000 | 12,500 | 37,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 12.50 | 2,000 | 25,000 | 38,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | E | 12.50 | 4,000 | 50,000 | 40,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 10.00 | 500 | 5,000 | 44,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 12.50 | 500 | 6,250 | 44,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 12.50 | 500 | 6,250 | 45,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 12.50 | 1,000 | 12,500 | 45,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 12.50 | 500 | 6,250 | 0 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 10.00 | 500 | 5,000 | 0 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 10.00 | 1,000 | 10,000 | 47,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 12.50 | 1,000 | 12,500 | 48,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 12.50 | 1,500 | 18,750 | 49,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 12.50 | 4,000 | 50,000 | 51,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 12.50 | 1,000 | 12,500 | 55,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 12.50 | 2,000 | 25,000 | 56,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 12.50 | 4,000 | 50,000 | 58,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 15.00 | 1,500 | 22,500 | 62,000 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 10.00 | 1,000 | 10,000 | 63,500 | |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 10.00 | 50,000 | 500,000 | 812,560 | 862.6 K to 812.6 K (-5.80 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 12.50 | 50,000 | 625,000 | 862,560 | 912.6 K to 862.6 K (-5.48 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 12.50 | 50,000 | 625,000 | 912,560 | 962.6 K to 912.6 K (-5.19 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 12.50 | 100,000 | 1,250,000 | 962,560 | 1.1 M to 962.6 K (-9.41 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 12.50 | 50,000 | 625,000 | 1,062,560 | 1.1 M to 1.1 M (-4.49 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 10.00 | 50,000 | 500,000 | 1,112,560 | 1.2 M to 1.1 M (-4.30 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 10.00 | 100,000 | 1,000,000 | 1,162,560 | 1.3 M to 1.2 M (-7.92 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 12.50 | 100,000 | 1,250,000 | 1,262,560 | 1.4 M to 1.3 M (-7.34 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 12.50 | 150,000 | 1,875,000 | 1,362,560 | 1.5 M to 1.4 M (-9.92 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 12.50 | 400,000 | 5,000,000 | 1,512,560 | 1.9 M to 1.5 M (-20.91 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 12.50 | 100,000 | 1,250,000 | 1,912,560 | 2 M to 1.9 M (-4.97 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 12.50 | 200,000 | 2,500,000 | 2,012,560 | 2.2 M to 2 M (-9.04 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 12.50 | 400,000 | 5,000,000 | 2,212,560 | 2.6 M to 2.2 M (-15.31 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 15.00 | 150,000 | 2,250,000 | 2,612,560 | 2.8 M to 2.6 M (-5.43 %) |
Mar 20 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 10.00 | 100,000 | 1,000,000 | 2,762,560 | 2.9 M to 2.8 M (-3.49 %) |
Mar 06 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 12.50 | 500 | 6,250 | 64,500 | |
Mar 06 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 12.50 | 1,000 | 12,500 | 64,000 | |
Feb 27 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 12.50 | 500 | 6,250 | 63,000 | |
Feb 27 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 12.50 | 500 | 6,250 | 62,500 | |
Feb 21 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 10.00 | 500 | 5,000 | 62,000 | |
Feb 21 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 10.00 | 500 | 5,000 | 61,500 | |
Feb 21 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 10.00 | 1,000 | 10,000 | 61,000 | |
Feb 21 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 10.00 | 1,000 | 10,000 | 60,000 | |
Feb 13 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 12.50 | 1,000 | 12,500 | 59,000 | |
Feb 13 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 12.50 | 1,000 | 12,500 | 58,000 | |
Feb 08 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 12.50 | 1,500 | 18,750 | 57,000 | |
Feb 08 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 12.50 | 1,500 | 18,750 | 55,500 | |
Feb 08 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 12.50 | 4,000 | 50,000 | 54,000 | |
Feb 08 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 12.50 | 2,000 | 25,000 | 50,000 | |
Feb 06 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 12.50 | 6,000 | 75,000 | 48,000 | |
Feb 06 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 10.00 | 500 | 5,000 | 42,000 | |
Feb 04 2013 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Buy | P | 11.89 | 1,000 | 11,890 | 4,375 | 3.4 K to 4.4 K (+29.63 %) |
Feb 04 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 12.50 | 1,000 | 12,500 | 41,500 | |
Feb 01 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 12.50 | 1,000 | 12,500 | 40,500 | |
Feb 01 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 12.50 | 1,000 | 12,500 | 39,500 | |
Feb 01 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 12.50 | 2,000 | 25,000 | 38,500 | |
Feb 01 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 12.50 | 2,000 | 25,000 | 36,500 |